Studies from our groups have established that PI(3,4)P2 directly promotes increased AKT activation and survival in a number of cancer cell types as introduction of exogenous PI(3,4)P2 into these cancer cells protects them from cell death induced by SHIP1-selective or pan-SHIP1/2 inhibitors [19,61]. Here, AKT1 is linked to cancer.